Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
- 28 February 2002
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 71 (1-2) , 333-340
- https://doi.org/10.1016/s0091-3057(01)00694-3
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Repeated administration of Δ9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the ratNeuropharmacology, 1999
- Hyperphagia in pre-fed rats following oral δ9-THCPublished by Elsevier ,1998
- Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female ratsLife Sciences, 1998
- Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor MechanismScience, 1997
- Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?Obesity Research, 1995
- Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJournal of Pain and Symptom Management, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990